Altria Q4 EPS In-Line but Revenue Misses, Where is the Growth? Scott Willis·January 30, 2020Altria (NYSE: MO) is sporting a juicy dividend rate, but recent write-offs on the JUUL investment are a...Investing·0 Comments·
Cronos Q4 2018 Earnings Review – The New Most Expensive Stock in Cannabis Scott Willis·March 26, 2019In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with operations. Impressive.Marijuana Analysis·1 Comment·
Altria Invests $2.4 Billion in Cronos Group Ty Arthur·March 8, 2019Altria Group, Inc. (NYSE: MO) today acquired 45% of cannabis company Cronos Group Inc. (NASDAQ: CRON; TSX: CRON)...Marijuana News·1 Comment·
Cronos – No Cash, No Deal….. Tough Times Scott Willis·December 6, 2018Cronos is running low on cash and without an Altria deal in sight, the company need to break-even...Marijuana Analysis·4 Comments·
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (October 13, 2018) Scott Willis·October 13, 2018Altria may be circling Aphria. Medmen does a transformative deal, Review of Aphria earnings and more......Marijuana News·0 Comments·
Altria has Aphria in their Crosshairs – What a Deal Would Mean for the Cannabis Industry Scott Willis·October 11, 2018Altria is rumoured to be seeking a direct minority stake in Aphria, we look at potential for such...Marijuana Analysis·0 Comments·
